EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations
Erik Thunnissen(Amsterdam UMC Location VUmc), Giulio Rossi(University of Modena and Reggio Emilia)
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
July 23, 2012
Cited by 211
Related Papers
Testing for ROS1 in non-small cell lung cancer: a review with recommendations
|Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2016|220
Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives
|Lung Cancer Targets and Therapy|2017|53
The value of c-kit mutational analysis in a cytokeratin positive gastrointestinal stromal tumour
|Journal of Clinical Pathology|2005|25
The “Brescia panel” (Claudin‐4 and BRCA‐associated protein 1) in the differential diagnosis of mesotheliomas with epithelioid features versus metastatic carcinomas
|Cancer Cytopathology|2020|24
<em>ROS1</em> rearrangements are uncommon in biliary tract cancers
|Oncology Letters|2020|1